Industrial Materials
Compare Stocks
4 / 10Stock Comparison
CRML vs UAMY vs MP vs NB
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial Materials
Industrial Materials
Industrial Materials
CRML vs UAMY vs MP vs NB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Industrial Materials | Industrial Materials | Industrial Materials | Industrial Materials |
| Market Cap | $1.52B | $1.54B | $12.28B | $723M |
| Revenue (TTM) | $561K | $39M | $305M | $0.00 |
| Net Income (TTM) | $-52M | $-4M | $-71M | $-55M |
| Gross Margin | 100.0% | 25.2% | 8.3% | — |
| Operating Margin | -84.6% | -21.5% | -36.4% | — |
| Forward P/E | — | 200.4x | 274.3x | — |
| Total Debt | $6M | $185K | $1.04B | $131K |
| Cash & Equiv. | $7M | $30M | $1.17B | $26M |
CRML vs UAMY vs MP vs NB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 24 | May 26 | Return |
|---|---|---|---|
| Critical Metals Cor… (CRML) | 100 | 103.8 | +3.8% |
| United States Antim… (UAMY) | 100 | 5190.8 | +5090.8% |
| MP Materials Corp. (MP) | 100 | 454.5 | +354.5% |
| NioCorp Development… (NB) | 100 | 229.5 | +129.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CRML vs UAMY vs MP vs NB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CRML has the current edge in this matchup, primarily because of its strength in growth exposure.
- Rev growth 376.5%, EPS growth 69.2%
- 376.5% revenue growth vs MP's 35.1%
- +7.2% vs NB's +147.5%
UAMY is the clearest fit if your priority is long-term compounding.
- 37.0% 10Y total return vs MP's 5.9%
- Better valuation composite
MP is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- beta 1.40
- Beta 1.40, current ratio 7.24x
- Beta 1.40 vs CRML's 3.15
- -2.0% ROA vs CRML's -30.2%, ROIC -4.7% vs -86.3%
NB is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.50, Low D/E 0.4%, current ratio 14.12x
- 0.1% margin vs CRML's -92.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 376.5% revenue growth vs MP's 35.1% | |
| Value | Better valuation composite | |
| Quality / Margins | 0.1% margin vs CRML's -92.5% | |
| Stability / Safety | Beta 1.40 vs CRML's 3.15 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +7.2% vs NB's +147.5% | |
| Efficiency (ROA) | -2.0% ROA vs CRML's -30.2%, ROIC -4.7% vs -86.3% |
CRML vs UAMY vs MP vs NB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
CRML vs UAMY vs MP vs NB — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
UAMY leads in 3 of 6 categories
MP leads 2 • CRML leads 0 • NB leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
UAMY leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MP and NB operate at a comparable scale, with $305M and $0 in trailing revenue. UAMY is the more profitable business, keeping -11.1% of every revenue dollar as net income compared to CRML's -92.5%. On growth, UAMY holds the edge at +89.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $560,624 | $39M | $305M | $0 |
| EBITDAEarnings before interest/tax | -$47M | -$7M | -$43M | -$25M |
| Net IncomeAfter-tax profit | -$52M | -$4M | -$71M | -$55M |
| Free Cash FlowCash after capex | -$16M | -$37M | -$314M | -$30M |
| Gross MarginGross profit ÷ Revenue | +100.0% | +25.2% | +8.3% | — |
| Operating MarginEBIT ÷ Revenue | -84.6% | -21.5% | -36.4% | — |
| Net MarginNet income ÷ Revenue | -92.5% | -11.1% | -23.3% | — |
| FCF MarginFCF ÷ Revenue | -27.7% | -95.5% | -102.8% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | +70.6% | +89.6% | +49.1% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +78.9% | — | +121.4% | — |
Valuation Metrics
UAMY leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.5B | $1.5B | $12.3B | $723M |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $1.5B | $12.2B | $698M |
| Trailing P/EPrice ÷ TTM EPS | -22.95x | -275.50x | -138.26x | -16.64x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 200.36x | 274.33x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | — |
| Price / SalesMarket cap ÷ Revenue | 2702.48x | 39.31x | 44.59x | — |
| Price / BookPrice ÷ Book value/share | 12.99x | 9.67x | 4.92x | 9.26x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — |
Profitability & Efficiency
MP leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MP delivers a -3.7% return on equity — every $100 of shareholder capital generates $-4 in annual profit, vs $-56 for CRML. UAMY carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to MP's 0.44x. On the Piotroski fundamental quality scale (0–9), CRML scores 6/9 vs NB's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -56.4% | -6.1% | -3.7% | -18.0% |
| ROA (TTM)Return on assets | -30.2% | -5.4% | -2.0% | -15.9% |
| ROICReturn on invested capital | -86.3% | -10.3% | -4.7% | -148.0% |
| ROCEReturn on capital employed | -85.6% | -9.7% | -4.2% | -47.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.06x | 0.00x | 0.44x | 0.00x |
| Net DebtTotal debt minus cash | -$1M | -$30M | -$123M | -$25M |
| Cash & Equiv.Liquid assets | $7M | $30M | $1.2B | $26M |
| Total DebtShort + long-term debt | $6M | $185,048 | $1.0B | $131,000 |
| Interest CoverageEBIT ÷ Interest expense | -82.34x | — | -2.80x | -249.13x |
Total Returns (Dividends Reinvested)
UAMY leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UAMY five years ago would be worth $126,116 today (with dividends reinvested), compared to $7,913 for NB. Over the past 12 months, CRML leads with a +718.5% total return vs NB's +147.5%. The 3-year compound annual growth rate (CAGR) favors UAMY at 2.2% vs NB's -0.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +58.3% | +85.8% | +25.8% | +0.7% |
| 1-Year ReturnPast 12 months | +718.5% | +190.8% | +192.7% | +147.5% |
| 3-Year ReturnCumulative with dividends | +15.1% | +3150.7% | +221.7% | -0.2% |
| 5-Year ReturnCumulative with dividends | +15.1% | +1161.2% | +149.7% | -20.9% |
| 10-Year ReturnCumulative with dividends | +15.1% | +3700.0% | +591.3% | -20.9% |
| CAGR (3Y)Annualised 3-year return | +4.8% | +2.2% | +47.6% | -0.1% |
Risk & Volatility
MP leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MP is the less volatile stock with a 1.40 beta — it tends to amplify market swings less than CRML's 3.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MP currently trades 69.0% from its 52-week high vs CRML's 40.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.15x | 1.88x | 1.40x | 1.50x |
| 52-Week HighHighest price in past year | $32.15 | $19.71 | $100.25 | $12.58 |
| 52-Week LowLowest price in past year | $1.29 | $1.94 | $18.64 | $2.17 |
| % of 52W HighCurrent price vs 52-week peak | +40.0% | +55.9% | +69.0% | +47.6% |
| RSI (14)Momentum oscillator 0–100 | 62.1 | 62.5 | 66.8 | 61.8 |
| Avg Volume (50D)Average daily shares traded | 12.5M | 12.4M | 5.6M | 4.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: UAMY as "Buy", MP as "Buy", NB as "Buy". Consensus price targets imply 56.1% upside for NB (target: $9) vs 13.2% for MP (target: $78).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $13.50 | $78.25 | $9.35 |
| # AnalystsCovering analysts | — | 4 | 11 | 2 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% |
UAMY leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). MP leads in 2 (Profitability & Efficiency, Risk & Volatility).
CRML vs UAMY vs MP vs NB: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is CRML or UAMY or MP or NB a better buy right now?
For growth investors, Critical Metals Corp.
(CRML) is the stronger pick with 376. 5% revenue growth year-over-year, versus 35. 1% for MP Materials Corp. (MP). Analysts rate United States Antimony Corporation (UAMY) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CRML or UAMY or MP or NB?
Over the past 5 years, United States Antimony Corporation (UAMY) delivered a total return of +1161%, compared to -20.
9% for NioCorp Developments Ltd. (NB). Over 10 years, the gap is even starker: UAMY returned +37. 0% versus NB's -20. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CRML or UAMY or MP or NB?
By beta (market sensitivity over 5 years), MP Materials Corp.
(MP) is the lower-risk stock at 1. 40β versus Critical Metals Corp. 's 3. 15β — meaning CRML is approximately 125% more volatile than MP relative to the S&P 500. On balance sheet safety, United States Antimony Corporation (UAMY) carries a lower debt/equity ratio of 0% versus 44% for MP Materials Corp. — giving it more financial flexibility in a downturn.
04Which is growing faster — CRML or UAMY or MP or NB?
By revenue growth (latest reported year), Critical Metals Corp.
(CRML) is pulling ahead at 376. 5% versus 35. 1% for MP Materials Corp. (MP). On earnings-per-share growth, the picture is similar: Critical Metals Corp. grew EPS 69. 2% year-over-year, compared to -150. 0% for United States Antimony Corporation. Over a 3-year CAGR, UAMY leads at 52. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CRML or UAMY or MP or NB?
NioCorp Developments Ltd.
(NB) is the more profitable company, earning 0. 0% net margin versus -92. 5% for Critical Metals Corp. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NB leads at 0. 0% versus -84. 6% for CRML. At the gross margin level — before operating expenses — CRML leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is CRML or UAMY or MP or NB more undervalued right now?
On forward earnings alone, United States Antimony Corporation (UAMY) trades at 200.
4x forward P/E versus 274. 3x for MP Materials Corp. — 74. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NB: 56. 1% to $9. 35.
07Which pays a better dividend — CRML or UAMY or MP or NB?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is CRML or UAMY or MP or NB better for a retirement portfolio?
For long-horizon retirement investors, MP Materials Corp.
(MP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+591. 3% 10Y return). Critical Metals Corp. (CRML) carries a higher beta of 3. 15 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MP: +591. 3%, CRML: +15. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CRML and UAMY and MP and NB?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CRML is a small-cap high-growth stock; UAMY is a small-cap high-growth stock; MP is a mid-cap high-growth stock; NB is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.